Home / Brands / Generic Peptides / Generic Peptides Adipotide 5 and 10 mg Lyophilized Vial Options
Generic Peptides Adipotide 5 and 10 mg Lyophilized Vial Options
Generic Peptides Adipotide 5 and 10 mg Lyophilized Vial Options
Generic Peptides

Generic Peptides Adipotide 5 and 10 mg Lyophilized Vial Options

Injection · 5 mg · vial

Out of stock
$85.00

Generic Peptides Adipotide is prohibitin-targeting peptide 1, a proapoptotic peptidomimetic supplied as a lyophilized research powder in two vial sizes: 5 mg and 10 mg.

GMP-manufactured, each batch is HPLC-verified with the Certificate of Analysis on file for every lot. Adipotide for sale as a research material with international shipping and dispatch within two business days after payment.

Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted

Product overview

Generic Peptides Adipotide - 5 and 10 mg Research Vials

Generic Peptides Adipotide is prohibitin-targeting peptide 1, a proapoptotic peptidomimetic supplied as a lyophilized research powder in 5 mg and 10 mg vials. Its design joins a homing sequence that binds ANXA2 and prohibitin on the endothelium of white adipose tissue to a KLAKLAK domain that disrupts mitochondria and triggers apoptosis in those vessel cells, so it is studied as a way to cut the blood supply of a fat depot. It sits in the fat-focused group of this line beside AOD-9604 and the GHRH analog Tesamorelin.

  • Two vial sizes - 5 and 10 mg
  • Fat-vasculature homing block with proapoptotic domain
  • Lyophilized powder
  • GMP-made, HPLC-verified, COA

Variant Comparison

Both vials hold the same peptidomimetic; only the amount of powder differs.

Variant Dosage Form and quantity Best use
Adipotide 5 mg 5 mg Vial Short
Adipotide 10 mg 10 mg Vial Extended

The 10 mg vial carries twice the powder of the 5 mg vial and suits longer sampling runs, while the 5 mg size keeps material use low. The lipolytic fragment HGH Frag 176-191 and the direct hormone Somatropin are the usual companions when a fat-tissue read-out is compared with a growth hormone signal.

How Adipotide Works

The homing block binds prohibitin and ANXA2 on the surface of the endothelial cells that feed white adipose tissue, and the KLAKLAK domain then collapses their mitochondria. Because those vessel cells are removed first, the fat depot is left without a blood supply. In the published primate study a 28-day daily schedule produced about 10.6 percent body-weight loss with better insulin sensitivity, and the same work recorded dose-dependent renal tubule changes that stopped the programme from advancing.

Reconstitution & Storage

Add bacteriostatic water down the wall of the vial and swirl, do not shake. Divide the milligrams on the vial by the millilitres added to read mg per mL: a 5 mg vial with 2 mL gives 2.5 mg/mL, so 0.1 mL on a U-100 syringe reads 250 mcg. Keep the sealed powder at 2-8 C or -20 C and the mixed solution at 2-8 C.

Dosage & Administration

No human dose is stated here and the vial is not a medicine. Adipotide was never approved and its early human programme was halted, so nothing on this page is a treatment protocol or a dosing guide.

For laboratory research only, not for human or veterinary use. Information provided is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before use. Adipotide is supplied as a lyophilized powder and stays stable when the vial is kept cold and dry.

Specifications

Trade NameAdipotide
Generic NameProhibitin-targeting peptide 1
ManufacturerGeneric Peptides
Dosage5 mg or 10 mg per vial
PackageLyophilized powder, one vial
Drug ClassPeptide; proapoptotic peptidomimetic
AdministrationSubcutaneous (research protocols)
StoragePowder at 2-8 C or -20 C
Prescription StatusResearch use only
VerificationBatch details confirmed with supplier
ShippingInternational about USD 35; no USA option on this page

Stacks

Fat Tissue Vasculature Model

Adipotide beside AOD-9604 in separate groups, one acting on the vessels of white adipose tissue and one on the lipolytic end of growth hormone.

Expected outcome: a read-out that separates vessel-directed tissue loss from direct lipolysis.

Fragment Comparison

Adipotide together with HGH Frag 176-191 and AOD-9604 held apart, so a proapoptotic mechanism is not confused with a lipolytic one.

Expected outcome: three separate fat-signal curves from three different mechanisms.

Hormone Axis Control

Adipotide as the vessel arm and Tesamorelin as the GHRH arm, studied in separate groups to keep the fat read-out away from the growth hormone axis.

Expected outcome: a clear separation between tissue-directed and endocrine fat signals.

For laboratory research only. Consult a healthcare professional before handling any peptide. Amounts shown are research references, not recommended human doses.

FAQ

Before you ask

Questions, answered

Adipotide is the trade name of prohibitin-targeting peptide 1, a synthetic peptidomimetic built from a homing sequence joined to a proapoptotic domain. Its structure is written CKGGRAKDC-GG-D(KLAKLAK)2, its CAS number is 859216-15-2 and its PubChem identifier is 163360068. It is supplied as a research material and holds no approved use in any country.

The homing block binds ANXA2 and prohibitin on the endothelial cells that supply white adipose tissue, and the KLAKLAK domain then disrupts their mitochondria and drives apoptosis. Once those vessel cells are gone the fat depot loses its blood supply. In the published primate study a 28-day daily schedule produced about 10.6 percent weight loss alongside improved insulin sensitivity.

Adipotide has no approved human use, so no label-based safety profile exists for it. In obese rhesus macaques the same study recorded dose-dependent changes in the renal tubules, and that kidney signal was the reason the development programme was stopped. Injection-site reactions are common to the route, and effects on vessels outside the target tissue cannot be measured without human data.

It reached an early human stage: the developer announced dosing of a first patient with a once-daily subcutaneous schedule over 28 days and several dose levels planned. The programme did not continue, and no completed human efficacy data for weight loss has been published. Everything described on this page therefore comes from animal work and from the structure of the compound.

Add bacteriostatic water down the side of the vial and swirl, do not shake. Divide the milligrams on the vial by the millilitres added to read mg per mL: a 5 mg vial with 2 mL gives 2.5 mg/mL, so 0.1 mL on a U-100 syringe reads 250 mcg. Keep the sealed powder at 2-8 C or -20 C and the mixed solution at 2-8 C.

The compound is not named in the WADA Prohibited List, and no separate anti-doping guidance for it was found. That is an absence of data rather than a statement that it is permitted, and any athlete under anti-doping rules should treat an unlisted research peptide as a risk rather than a clearance. Rules change, so the current list is the only authority.

Both vial sizes are listed on this page as research material with international checkout. International shipping runs about 35 dollars with a transit window of four to ten days, and orders are handled within one to two business days. The U.S. domestic option is not open for this compound, so only the international route applies. Stock and prices are shown in the options above.

No reviews yet

Be the first to share your experience with Generic Peptides Adipotide 5 and 10 mg Lyophilized Vial Options

Log in to write a review

Complete the cycle

Stack it with

View all